CHAC, typically downregulated in GBM cell lines, was identified as a key gene up-regulated by TMZ treatment, enhancing glioma apoptotic death and inhibiting Notch3-mediated pathways [57]. This evidence concerns the gene NOTCH3 and central nervous system cancer.